| Name | Title | Contact Details |
|---|---|---|
Heather Clark |
Sr Director, HR Business Partner | Profile |
Greg Fly |
Vice President Procurement Global RandD | Profile |
Jacques Goldenberg |
Interim VP HR, RandD, Global Partnering and HR Lead of Epizyme integration | Profile |
Christelle Huguet |
Head of Research, External Innovation and Early Development | Profile |
Jennifer Glennon |
Vice President, Chief of Staff, Head of Finance, Research and Development at Ipsen | Profile |
Teva api is an international pharmaceutical company headquartered in Israel.
National Diabetic Pharmacies is a Salem, VA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
3129 Sanofi SA is a French multinational healthcare company headquartered in Paris, France.
All of Ankas programs share the same mission: to eliminate the impact of behavioral health problems for all people.
Aeterna Zentaris Inc. is a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. The Company`s lead product, Macrilen™ (macimorelin), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). Macrilen™ is currently marketed in the United States through a license agreement with Novo Nordisk and Aeterna Zentaris receives double-digit royalties on sales. Aeterna Zentaris owns all rights to macimorelin outside of the U.S. and Canada. Aeterna Zentaris is also leveraging the clinical success and compelling safety profile of macimorelin to develop it for the diagnosis of child-onset growth hormone deficiency (CGHD), an area of significant unmet need. The Company is actively pursuing business development opportunities for the commercialization of macimorelin in Europe and the rest of the world, in addition to other non-strategic assets to monetize their value.